Journey Medical Corp. (DERM) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$7.36

From 52W high−21.06%

Volume259739.00

Market cap$206.32M

P/E (TTM)—

P/S (TTM)3.0x

Div yield—

Key dataSep 18, 2026

Open

$7.36

From 52W high

−21.06%

Volume

259739.00

Market cap

$206.32M

ValuationView details →

P/E (Fwd)

37.0x

EV/EBITDA

111.5x

P/E (TTM)

—

RSI (14)

51.9

MomentumView details →

1D Return

−0.68%

YTD Return

−4.47%

SummaryUpdated Jun 1, 2026

Journey Medical Corporation (NASDAQ:DERM) is a specialty pharmaceutical company founded in 2014 and headquartered in Scottsdale, Arizona. Originally incorporated as Coronado Dermatology, Inc., the company went public in November 2021 and focuses exclusively on developing and commercializing prescription treatments for dermatological conditions. Journey Medical has built a portfolio of FDA-approved dermatology products targeting conditions such as severe acne, hyperhidrosis (excessive sweating), rosacea, and various topical skin infections, serving the specialized needs of dermatologists and their patients across the United States.

Ask drillr about Journey Medical Corp. →

ValuationView details →

P/E (Fwd)

37.0x

P/E (TTM)

—

EV/EBITDA

111.5x

EV/Sales

3.0x

P/S (TTM)

3.0x

P/B (TTM)

6.4x

ProfitabilityView details →

Gross Margin

62.24%

Net Margin

−8.95%

EBITDA Margin

2.71%

ROE (TTM)

−19.01%

ROA (TTM)

−6.21%

Asset Turnover

0.72x

GrowthView details →

Revenue YoY

+20.89%

EPS YoY

+42.27%

FCF YoY

—

Revenue CAGR 3Y

−5.66%

EPS CAGR 3Y

+34.72%

EBITDA YoY

+255.64%

MomentumView details →

1D Return

−0.68%

YTD Return

−4.47%

1Y Return

+0.89%

RSI (14)

51.9

vs 50D SMA

+4.82%

vs 200D SMA

+6.34%

Capital & dividendView details →

Debt/Equity

0.80x

Current Ratio

1.59x

Quick Ratio

1.41x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.01

EPS Surprise

55.56%

Beats (12Q)

4/12

Next Q EPS Est

$0.02

Avg Surprise (4Q)

15.53%

Rev Surprise

0.82%

Financials snapshotView financials →

Revenue (TTM)

68.18M

Net Income (TTM)

−6.10M

Op. CF (TTM)

−7.49M

Next earningsNov 11, 2026 →

Latest newsMore news →

Starbucks opened its first Starbucks Reserve store in South India, located in Hyderabad, as the sixth Reserve outlet in India.30d ago

Journey Medical Corp reported Q2 2026 revenue of $18.5 million, up 23% year-over-year, with a GAAP net loss of $0.3 million and non-GAAP adjusted EBITDA of $2.862 million.40d ago

Similar companies

Extrawell Pharmaceutical Holdings Limited00858.HK SIGA Technologies, Inc.SIGA Cardiol Therapeutics Inc.CRDL Organogenesis Holdings Inc.ORGO Tianda Pharmaceuticals Limited00455.HK China NT Pharma Group Company Limited01011.HK Find similar companies →

Latest newsMore news →

Starbucks opened its first Starbucks Reserve store in South India, located in Hyderabad, as the sixth Reserve outlet in India.30d ago Journey Medical Corp reported Q2 2026 revenue of $18.5 million, up 23% year-over-year, with a GAAP net loss of $0.3 million and non-GAAP adjusted EBITDA of $2.862 million.40d ago